DanSchullerMD

Pulmonology • El Paso, TX

Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine

Chair and Professor

Join to view full profile

Dr. Schuller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schuller's full profile

Already have an account?

Office
2000 B Trans Mountain Rd
El Paso, TX 79911
Phone+1 915-215-8400

Fax+1 915-612-9254

Summary

Dr. Dan Schuller is a pulmonologist in El Paso, TX and is affiliated with The Hospitals of Providence Transmountain Campus. He received his medical degree from Universidad Nacional Autonoma de Mexico and has been in practice 33 years. He also speaks multiple languages, including Spanish and Hebrew. He specializes in critical care medicine, pleural disease, and pulmonary vascular medicine and is experienced in pulmonary hypertension, asthma, chronic obstructive pulmonary disease, interstitial lung disease, and critical care medicine.

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1992
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1985 - 1988
Universidad Nacional Autonoma de MexicoClass of 1984

Certifications & Licensure

TX State Medical License 2013 - 2025
NE State Medical License 2002 - 2014
IA State Medical License 2002 - 2013
MI State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Fellow (FACP) American College of Physicians, 2002

Clinical Trials

Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints Start of enrollment: 2005 Dec 01
Completed
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism Start of enrollment: 2008 May 01
Completed
Phase 3
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension Start of enrollment: 2009 Mar 12
Completed
Phase 3
Imatinib (QTI571) in Pulmonary Arterial Hypertension Start of enrollment: 2009 Sep 01
Completed
Phase 3
Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2010 Apr 01
Terminated
Phase 3
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2010 Oct 01
Completed
Phase 3
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2012 Apr 01
Completed
Phase 3
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance Start of enrollment: 2012 May 01
Completed
Phase 1
AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients Start of enrollment: 2013 Jan 01
Completed
Phase 3
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
No longer available
Join now to see all

Publications & Presentations

PubMed

2 citations
Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models.
Kahtan Fadah, Jose B Cruz Rodriguez, Haider Alkhateeb, Debabrata Mukherjee, Hernando Garcia
Pulmonary Circulation. 2023-04-01
Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection.
Hemanshi Y Mistry, Dominic Betancourt, Dan Schuller, Jonathan Lavezo
Cureus. 2023-03-01
Paraneoplastic Hypereosinophilia in Poorly Differentiated Adenocarcinoma of the Lung.
Sarah Ream, Piruthiviraj Natarajan, Shruti Gupta, Elsa Sotelo-Rafiq, Dan Schuller
Cureus. 2023-01-01

Committees

Hospital of Providence -Transmountain, Medical Executive Committee 2018 - Present
Chair, Critical Care Counsel 2014 - 2018
Member, GME committee at Baylor University Medical Cenetr 2013 - 2018